Myriad Genetics Market Cap

Myriad Genetics has a market cap or net worth of $651.56 million as of December 15, 2025. Its market cap has decreased by -55.74% in one year.

Market Cap

651.56M

Enterprise Value

718.46M

1-Year Change

-55.74%

Ranking

#2858

Market Cap Chart

Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $651.56M, an increase of 536.91%. That is a compound annual growth rate of 7.08%.

Market Cap History

Date	Market Cap	% Change
Dec 12, 2025	672.10M	-46.15%
Dec 31, 2024	1.25B	-20.67%
Dec 29, 2023	1.57B	33.81%
Dec 30, 2022	1.18B	-46.65%
Dec 31, 2021	2.20B	48.19%
Dec 31, 2020	1.49B	-26.57%
Dec 31, 2019	2.03B	-6.80%
Dec 31, 2018	2.17B	-8.61%
Dec 29, 2017	2.38B	108.51%
Dec 30, 2016	1.14B	-62.13%
Dec 31, 2015	3.01B	21.14%
Dec 31, 2014	2.49B	58.51%
Dec 31, 2013	1.57B	-29.30%
Dec 31, 2012	2.22B	25.03%
Dec 30, 2011	1.77B	-15.91%
Dec 31, 2010	2.11B	-15.93%
Dec 31, 2009	2.51B	-18.54%
Dec 31, 2008	3.08B	50.95%
Dec 31, 2007	2.04B	64.00%
Dec 29, 2006	1.24B	93.29%
Dec 30, 2005	643.90M	-6.71%
Dec 31, 2004	690.20M	98.11%
Dec 31, 2003	348.40M	-0.17%
Dec 31, 2002	349.00M	-71.84%
Dec 31, 2001	1.24B	-34.15%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	920.02B
Johnson & Johnson	509.76B
AbbVie	394.69B
UnitedHealth Group	309.65B
AstraZeneca	278.45B
Novartis AG	254.39B
Merck & Co.	248.95B
Novo Nordisk	224.22B

Market Cap Rankings